Development Level

Tbio 44 | 11,445
Tdark 6 | 6,588

IMPC Phenotype

preweaning lethality, incomple... 3 | 499
decreased total body fat amoun... 2 | 207
increased total body fat amoun... 2 | 134
abnormal behavior 1 | 298
abnormal eye morphology 1 | 68
abnormal response to new envir... 1 | 10
abnormal response to tactile s... 1 | 17
abnormal sleep behavior 1 | 70
abnormal thymus morphology 1 | 7
alopecia 1 | 1
decreased IgE level 1 | 6
decreased body weight 1 | 161
decreased bone mineral density 1 | 126
decreased circulating HDL chol... 1 | 68
decreased circulating alkaline... 1 | 46
decreased circulating choleste... 1 | 93
decreased circulating creatini... 1 | 39
decreased circulating insulin ... 1 | 76
decreased circulating lactate ... 1 | 3
decreased hemoglobin content 1 | 68
decreased large unstained cell... 1 | 11
increased anti-nuclear antigen... 1 | 19
increased bone mineral content 1 | 108
increased bone mineral density 1 | 72
increased circulating glucose ... 1 | 24
increased circulating serum al... 1 | 22
increased erythrocyte cell num... 1 | 39
increased exploration in new e... 1 | 8
increased heart weight 1 | 62
increased hematocrit 1 | 46
increased lean body mass 1 | 172
mammalian phenotype 1 | 17
short tibia 1 | 97
small thymus 1 | 16
tremors 1 | 39
trunk curl 1 | 16

Disease

Carcinoma 36 | 11,493
medulloblastoma, large-cell 28 | 6,241
ovarian cancer 28 | 8,520
glioblastoma 27 | 5,792
osteosarcoma 25 | 7,950
psoriasis 23 | 6,694
atypical teratoid / rhabdoid tumor 22 | 5,112
ependymoma 21 | 4,679
Astrocytoma, Pilocytic 19 | 3,081
group 3 medulloblastoma 19 | 4,104
oligodendroglioma 19 | 2,850
astrocytic glioma 16 | 2,597
lung carcinoma 16 | 2,843
lung cancer 15 | 4,740
adult high grade glioma 13 | 3,801
invasive ductal carcinoma 12 | 2,951
interstitial cystitis 11 | 2,312
intraductal papillary-mucinous adenoma (IPMA) 11 | 2,955
Pick disease 10 | 1,894
group 4 medulloblastoma 10 | 1,855
malignant mesothelioma 10 | 3,232
primitive neuroectodermal tumor 10 | 3,035
intraductal papillary-mucinous carcinoma (IPMC) 9 | 2,989
pancreatic cancer 9 | 2,398
pituitary cancer 9 | 1,972
subependymal giant cell astrocytoma 9 | 2,287
tuberculosis 9 | 2,010
Breast cancer 8 | 3,578
intraductal papillary-mucinous neoplasm (IPMN) 8 | 3,291
non-small cell lung cancer 8 | 2,890
pancreatic ductal adenocarcinoma liver metastasis 8 | 1,962
ductal carcinoma in situ 7 | 1,745
pediatric high grade glioma 7 | 1,064
Hypomyelinating leukodystrophy 6 6 | 26
Multiple myeloma 6 | 1,332
juvenile dermatomyositis 6 | 1,187
lung adenocarcinoma 6 | 2,716
Kidney cancer 5 | 2,613
Schizophrenia 5 | 1,160
astrocytoma 5 | 1,146
colon cancer 5 | 1,478
dermatomyositis 5 | 966
nasopharyngeal carcinoma 5 | 1,058
Botulism 4 | 24
Duchenne muscular dystrophy 4 | 601
Griscelli syndrome 4 | 24
Melanoma 4 | 711
Tetanus 4 | 68
Vici syndrome 4 | 14
Waldenstrons macroglobulinemia 4 | 765
acute quadriplegic myopathy 4 | 1,158
breast carcinoma 4 | 1,638
primary pancreatic ductal adenocarcinoma 4 | 1,109
spina bifida 4 | 1,074
ulcerative colitis 4 | 1,819
Chronic Lymphocytic Leukemia 3 | 262
Gaucher disease type 1 3 | 180
Neurodegenerative disease 3 | 414
Rheumatoid arthritis 3 | 1,191
Skin cancer 3 | 469
active Crohn's disease 3 | 922
active ulcerative colitis 3 | 764
adrenocortical carcinoma 3 | 1,428
diabetes mellitus 3 | 1,728
head and neck cancer 3 | 271
pancreatic carcinoma 3 | 562
Alzheimer's disease 2 | 658
Attention deficit hyperactivity disorder 2 | 278
Autosomal recessive limb-girdle muscular dystrophy type 2B 2 | 5
Bipolar Disorder 2 | 666
Cancer 2 | 2,499
Disease of anatomical entity 2 | 32
Distal muscular dystrophy 2 | 8
Down syndrome 2 | 499
Hermansky-Pudlak syndrome 2 | 42
Liver cancer 2 | 604
MAJOR AFFECTIVE DISORDER 2 2 | 22
Mental Depression 2 | 333
Oppositional defiant disorder 2 | 17
Osteoporosis 2 | 363
Pancreatic agenesis 2 | 17
Parkinson's disease 2 | 392
Prostatic Neoplasms 2 | 495
Round face 2 | 45
Round, full face 2 | 45
atypical teratoid/rhabdoid tumor 2 | 357
autosomal recessive nonsyndromic deafness 9 2 | 6
cutaneous lupus erythematosus 2 | 1,057
cystic fibrosis 2 | 1,696
fibroadenoma 2 | 559
gastric cancer 2 | 459
head and neck cancer and chronic obstructive pulmonary disease 2 | 239
non primary Sjogren syndrome sicca 2 | 891
periodontitis 2 | 293
progressive supranuclear palsy 2 | 676
urothelial carcinoma 2 | 318
Bladder exstrophy 1 | 32
Rapidly progressive 1 | 27
Rapidly progressive disorder 1 | 27
Supranuclear gaze palsy 1 | 6

Tissue

Digestive Tract 48 | 17,369
Endocrine System 48 | 18,159
Female tissues 48 | 17,400
Male tissues 48 | 17,142
Urinary Tract 48 | 16,678
Liver and Pancreas 47 | 16,750
Nervous System 47 | 16,725
Respiratory system 45 | 16,393
Skin and soft tissues 45 | 17,230
Blood and immune system 42 | 16,909
Cardiovascular System 40 | 15,192

Target Family

Non-IDG 49 | 12,091
Epigenetic 1 | 242

GO Process

vesicle fusion 50 | 50
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Synaptotagmin-15 SYT15 Tdark Non-IDG -0.22617 1.25 9
Synaptotagmin-2 SYT2 Tbio Non-IDG -1.93503 86.7 222
C2 domain-containing protein 5 C2CD5 Tbio Non-IDG -0.04792 1.71 33
Syntaxin-8 STX8 Tbio Non-IDG -2.59234 391.5 134
Synaptotagmin-like protein 2 SYTL2 Tbio Non-IDG -1.27949 19.5 60
Synaptotagmin-7 SYT7 Tbio Non-IDG -1.75931 60.3 170
Synaptotagmin-like protein 3 SYTL3 Tbio Non-IDG -1.02669 10.4 84
Lymphoid-restricted membrane protein LRMP Tbio Non-IDG -1.19402 16.8 65
Caveolin-2 CAV2 Tbio Non-IDG -2.43448 254.2 294
Synaptotagmin-14 SYT14 Tdark Non-IDG -0.71321 4.64 25